| 1 |
Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH. Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024; 403(10427): 683-98.
doi: 10.1016/S0140-6736(23)01736-1
pmid: 38368016
|
| 2 |
Sacoto G, Boukhlal S, Specks U, Flores-Suárez LF, Cornec D. Lung involvement in ANCA-associated vasculitis. Presse Med. 2020; 49(3): 104039.
|
| 3 |
Quadrelli S, Dubinsky D, Solis M, Yucra D, Hernández M, Karlen H, et al. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med. 2017; 129: 59-62.
doi: S0954-6111(17)30169-5
pmid: 28732837
|
| 4 |
Al-Adhoubi NK, Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus. 2020; 29(4): 355-63.
doi: 10.1177/0961203320903798
pmid: 32036761
|
| 5 |
Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond). 2017; 17(1): 60-4.
doi: 10.7861/clinmedicine.17-1-60
pmid: 28148583
|
| 6 |
Álamo BS, Moi L, Bajema I, Faurschou M, Flossmann O, Hauser T, et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2023; 38(7): 1655-65.
|
| 7 |
Park JA. Treatment of diffuse alveolar hemorrhage: controlling inflammation and obtaining rapid and effective hemostasis. Int J Mol Sci. 2021; 22(2): 793.
|
| 8 |
Casal Moura M, Gauckler P, Anders HJ, Bruchfeld A, Fernandez-Juarez GM, Floege J, et al. Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations. Nephrol Dial Transplant. 2023; 38(11): 2637-51.
|
| 9 |
Walsh M, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020; 382(7): 622-31.
|
), Xiaoye Mo(
